Cexiong (winston) Fu PhD

Cexiong (Winston) Fu has more than 10 years of experience in the development of various biotherapeutics modalities, receiving his Ph.D. from North Carolina State University and B.S from Peking University. Winston is currently an analytical product owner at Takeda and is responsible for defining the research to development transition strategy for all new biotherapeutic candidates within Shire/Takeda and for supporting developability assessment, analytical development plan, and CMC activities. Prior to joining Shire/Takeda in 2018, Winston has worked in Abbvie and Pfizer on biologics ADME, biosimilar analytical characterization, and ADC characterization and bioanalysis.